SNY
Sanofi
Stock
$39.92−0.75 (−1.84%)Close Oct 2, 2026
Cash flow statement
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | €10.8B | €9.1B | €10.3B | €10.5B | €10.5B | €7.4B | €7.7B | €5.5B | €7.4B | €7.8B | €8.3B |
| Capital expenditures | €3.5B | €3.2B | €2.9B | €2.1B | €2.0B | €2.1B | €1.8B | — | — | — | — |
| Free cash flow | €7.2B | €5.9B | €7.4B | €8.4B | €8.5B | €5.3B | €5.9B | — | — | — | — |
| Stock-based compensation | €313M | €278M | €260M | €234M | €244M | €274M | €252M | €284M | €263M | €241M | €193M |
| Buybacks | €5.0B | €302M | €593M | €497M | €382M | €822M | €9.0M | €1.1B | €2.2B | €2.9B | €1.8B |